Komori
Sundrug (9989) · FactRestated

Retirement of the Representative Director and President, and the Chairman concurrently serving as President

First written in FY2019-Q1. 2 of 5 entries say "Restated". Latest entry: FY2023.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019-Q1 – FY2019-Q2ReframedFY2019 – FY20222018: 220182019: 120192020: 020202021: 020212022: 120222023: 12023
Same theme, other companies
Transition to a Representative Director, Chairman and President and CEO StructureA theme 19 companies write about · 0 as a headwind · 1 as a tailwind

Sundrug moved to the "Worse" side of this theme in 2019, 5 years before the typical company in this theme (2024).

The whole theme swung hardest in 2022: 4 of 8 companies on the "Worse" side.

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「April 2022 Company Representative Director and President, CEO (current) / April 2022 Company Director and Chairman (current)」

    Continues the officer structure comprising a Representative Director and President, CEO, and a Director and Chairman.
  2. FY2022ReframedAnnual report

    「April 2022 Company Representative Director and President, CEO (current) / April 2022 Company Director and Chairman (current)」

    The titles changed from the structure following the 2019 change in President to titles under which the Representative Director and President also serves as CEO and a Director and Chairman position was established.
  3. FY2019ReframedAnnual report

    「May 2019 Company Representative Director and Chairman (current) / May 2019 Company Representative Director and President (current)」

    The structure changed from the previous Chairman-and-President arrangement in May 2019 to one in which Saizu (才津) serves solely as Chairman and Sadakata (貞方) becomes Representative Director and President.
  4. FY2019-Q2RestatedAnnual report

    「Representative Director and President Head of the Administration Division Akao Shusa (赤尾 主哉) 5 August 2018 / Representative Director, Chairman and President Representative Director and Chairman Saizu Tatsuro (才津 達郎) 6 August 2018」

    The retirement of the Representative Director and President and the change in position of the Representative Director and Chairman to Representative Director, Chairman and President were reiterated in the officer information.
  5. FY2019-Q1First statedAnnual report

    「The changes in officers after the end of the cumulative first-quarter period are as follows. (1) Retiring officer Representative Director and President Head of the Administration Division Akao Shusa (赤尾 主哉) 5 August 2018 (2) Change in officer position New position: Representative Director, Chairman and President Former position: Representative Director and Chairman Name: Saizu Tatsuro (才津 達郎) Date of change: 6 August 2018」

    The filing stated that, as a change in officers after submission, the Representative Director and President retired and the Representative Director and Chairman changed to Representative Director, Chairman and President.
Moved together

"Impact of adverse weather and slowing sales of inbound tourism-related products on drugstore same-store sales" moved the same way as this thread, in the same document, in 2 of its 5 moves.

22★12
  1. ★This thread
  2. 1Impact of adverse weather and slowing sales of inbound tourism-related products on drugstore same-store sales2×
  3. 2Risk of litigation and regulatory action due to dispensing errors or defects in dispensed medicines2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sundrug yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.